Leidos Holdings Operating Cash Flow decreased by 39.2% to $301.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 419.0%, from $58.00M to $301.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 14.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $239.00M | $17.00M | $565.00M | $212.00M | $93.00M | $45.00M | $729.00M | $125.00M | -$98.00M | $164.00M | $795.00M | $326.00M | $113.00M | $381.00M | $647.00M | $294.00M | $58.00M | $486.00M | $711.00M | $495.00M | $301.00M |
| QoQ Change | — | -92.9% | >999% | -62.5% | -56.1% | -51.6% | >999% | -82.9% | -178.4% | +267.3% | +384.8% | -59.0% | -65.3% | +237.2% | +69.8% | -54.6% | -80.3% | +737.9% | +46.3% | -30.4% | -39.2% |
| YoY Change | — | — | — | — | -61.1% | +164.7% | +29.0% | -41.0% | -205.4% | +264.4% | +9.1% | +160.8% | +215.3% | +132.3% | -18.6% | -9.8% | -48.7% | +27.6% | +9.9% | +68.4% | +419.0% |